The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated ...

People aged 50 and over and those who are immunocompromised are more at risk of getting shingles, as well as developing a ...

Shingles is a funny-sounding name for a seriously painful disease. How painful? That’s hard to put into words. Printable ones ...

The host factors that drive adaptive substitutions in the influenza virus remain poorly understood. Here, Zou et al. identify GGCX as a key determinant for the adaption of Eurasian avian-like H1N1 ...

Many of us think of chickenpox as a childhood illness — a harmless rite of passage that fades into memory once the itchy ...

One year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to Shingrix SEATTLE, Jan. 12, 2025 (GLOBE NEWSWIRE) -- (Curevo), a ...

In the present manuscript, we will focus on encephalitis caused by HSV, HIV and varicella zoster virus (VZV) and describe the most recent understanding of the findings of neuroimaging studies on ...

These two reports address the effects of varicella-zoster vaccination and varicella vaccination. Richard Whitley, who chaired the data and safety monitoring board for the Shingles Prevention Study ...

Can head trauma cause Alzheimer’s? Yes, by reactivating dormant brain viruses like HSV-1, triggering inflammation and ...